The popular growth investor keeps adding to some of her favorite stocks.

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

Intellia Therapeutics, Inc.’s NTLA share price has surged by 5.05%, which has investors questioning if this is right time to ...

Cathie Wood, the renowned investor and co-founder of Ark Invest, has made headlines again with her recent stock purchases. On Tuesday, Wood added to her stakes in Advanced Micro Devices (AMD), Shopify ...

ARK Invest made significant trades in NTLA, META, VCYT, SYM, BIDU, and PATH. These moves come amidst changes in stock prices.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Intellia To Contact Him Directly To Discuss Their Options If ...

If you suffered a loss in Intellia you have until April 14, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as ...

Cathie Wood's ARK Invest has increased its stake in a Chinese technology giant an equity favored by Michael Burry.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

Intellia Therapeutics, Inc. (NTLA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, NTLA broke out above the 50-day moving ...